Cantex Pharmaceuticals

About:

Cantex Pharmaceuticals is a biotechnology company engaged in harnessing known therapies to develop novel and safer cancer treatments.

Website: http://cantex.com

Top Investors: Domain Associates, Research Corporation Technologies, CHL Medical Partners, The Aurora Funds, Venture Academy

Description:

Cantex Pharmaceuticals is a biotechnology company engaged in harnessing known therapies to develop novel and safer cancer treatments. Cantex is currently conducting two unique development programs with modified versions of two separate known chemical entities each of which addresses major unmet medical needs representing high-value market opportunities:

Total Funding Amount:

$33.6M

Headquarters Location:

Weston, Florida, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)cantex.com

Founders:

Stephen Marcus

Number of Employees:

1-10

Last Funding Date:

2014-04-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai